## **Core Concept**
The clinical presentation described points towards a diagnosis of **hydatidiform mole**, a type of gestational trophoblastic disease (GTD) characterized by abnormal trophoblastic proliferation and hydropic degeneration of chorionic villi. The presence of a high plasma human chorionic gonadotropin (hCG) level and the ultrasound findings further support this diagnosis. The condition is often associated with a **complete mole**, which typically has a diploid karyotype, commonly 46,XX, but can also be 46,XY as seen in this case.

## **Why the Correct Answer is Right**
The progression of hydatidiform mole to **choriocarcinoma**, a malignant form of gestational trophoblastic neoplasia (GTN), is a known complication. The risk of progression to choriocarcinoma is higher in complete moles compared to partial moles. Studies have shown that approximately **1-2%** of patients with a hydatidiform mole will develop choriocarcinoma. This risk is critical in guiding the follow-up and management of patients after the evacuation of a molar pregnancy.

## **Why Each Wrong Option is Incorrect**
- **Option A (10-20%)**: This option overestimates the risk of progression from hydatidiform mole to choriocarcinoma. While there is a risk of malignant transformation, the actual percentage is much lower.
- **Option B (20-30%)**: Similar to option A, this significantly overestimates the risk and does not accurately reflect the known clinical data on the progression to choriocarcinoma.
- **Option D (50-60%)**: This option grossly overestimates the risk. The actual risk is much lower, and such a high progression rate would be unusual for this condition.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **all patients with a hydatidiform mole require follow-up with serial hCG levels** after evacuation to monitor for potential progression to gestational trophoblastic neoplasia (GTN), including choriocarcinoma. This follow-up is crucial for early detection and treatment of any persistent gestational trophoblastic disease.

## **Correct Answer: B. 1-2%.**